GlassScriptPhysician profile
Ronald Frank Wolf
NPI 1649369935
$22,155.50
in general payments reported to CMS, 2019-2025
19 companies · $8,251 in 2025
The $8,251 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,609 · 2020: $5,462 · 2021: $3,176 · 2022: $424 · 2023: $2,267 · 2024: $967 · 2025: $8,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,750 · Food and Beverage: $2,115 · Travel and Lodging: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,750.00 |
| Food and Beverage | $2,114.94 |
| Travel and Lodging | $1,619.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,470.83 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Boston Scientific Corporation | $460.88 | 2023-2025 | Spyglass Discover, Axios, Spyglass |
| Medtronic, INC. | $351.15 | 2022-2025 | Signia, Valleylab Ft10, Ligasure |
| Abbvie INC. | $321.01 | 2024-2025 | |
| Intera Oncology, INC | $267.29 | 2022 | |
| Dova Pharmaceuticals | $199.07 | 2020-2021 | |
| Cook Medical LLC | $191.61 | 2019-2024 | Echotip Insight, Fusion |
| Integra Lifesciences Corporation | $124.31 | 2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Ipsen Biopharmaceuticals, INC | $123.80 | 2019 | |
| Medical Device Business Services, INC. | $122.64 | 2025 | Ethicon |
| Eisai INC. | $120.72 | 2020 | |
| Angiodynamics, INC. | $108.31 | 2019-2020 | |
| Ethicon US, LLC | $69.32 | 2023-2025 | Echelon Endopath, Echelon; Endopath, Certus 140 |
| Dilon Technologies, INC. | $67.57 | 2024 | Hemoblast Bellows |
| Olympus America INC. | $67.13 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.26 | 2024 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $28.67 | 2023 | Lynparza |
| Merck Sharp & Dohme LLC | $18.77 | 2023 | Bridion |
| Puma Biotechnology, INC. | $13.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.